HilleVax Balance Sheet Health
Financial Health criteria checks 6/6
HilleVax has a total shareholder equity of $184.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $220.6M and $36.3M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$189.31m |
| Equity | US$184.27m |
| Total liabilities | US$36.35m |
| Total assets | US$220.62m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: HLVX's short term assets ($197.2M) exceed its short term liabilities ($13.8M).
Long Term Liabilities: HLVX's short term assets ($197.2M) exceed its long term liabilities ($22.5M).
Debt to Equity History and Analysis
Debt Level: HLVX is debt free.
Reducing Debt: HLVX had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: HLVX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: HLVX has sufficient cash runway for 1.9 years if free cash flow continues to reduce at historical rates of 54.5% each year.